Explore the vast range of titles available.

Positron annihilation lifetime spectroscopy (PALS) provides a direct measurement of the free volume void sizes in polymers and biological systems. This free volume is critical in explaining and understanding physical and mechanical properties of polymers. Moreover, PALS has been recently proposed as a potential tool in detecting cancer at early stages, probing the differences in the subnanometer scale free volume voids between cancerous/healthy skin samples of the same patient. Despite several investigations on free volume in complex cancerous tissues, no positron annihilation studies of living cancer cell cultures have been reported. We demonstrate that PALS can be applied to the study in human living 3D cell cultures. The technique is also capable to detect atomic scale changes in the size of the free volume voids due to the biological responses to TGF-β. PALS may be developed to characterize the effect of different culture conditions in the free volume voids of cells grown in vitro.

We have studied the behaviour of defects in off-stoichiometric Ni-Mn-Ga ferromagnetic shape memory alloys by means of positron lifetime spectroscopy. The measurements presented in this work have been performed in six ternary alloys. The studied samples cover a large composition range. Positron experiments have been performed at room temperature after subsequent isochronal annealing at different temperatures up to a maximum temperature of 700°C. Results show a large variation of the average positron lifetime value with the isochronal annealing temperature in three of these samples, with significant differences between them. In the other three, the response is quite different. The results are discussed in terms of different types of positron trapping defects and their evolution with the annealing temperature. The present work shows a high dependence of recovery behaviour with composition in NiMnGa ferromagnetic shape memory alloys.

Positron annihilation lifetime spectroscopy (PALS) provides a direct measurement of the free volume void sizes in polymers and biological systems. This free volume is critical in explaining and understanding physical and mechanical properties of polymers. Moreover, PALS has been recently proposed as a potential tool in detecting cancer at early stages, probing the differences in the subnanometer scale free volume voids between cancerous/healthy skin samples of the same patient. Despite several investigations on free volume in complex cancerous tissues, no positron annihilation studies of living cancer cell cultures have been reported. We demonstrate that PALS can be applied to the study in human living 3D cell cultures. The technique is also capable to detect atomic scale changes in the size of the free volume voids due to the biological responses to TGF- beta . PALS may be developed to characterize the effect of different culture conditions in the free volume voids of cells grown in vitro.

Currently, many types of devices that have gained access to the network is large and diverse. The different capabilities and characteristics of them, in addition to the different characteristics and preferences of users, have generated a new goal to overcome: how to adapt the contents taking into account this heterogeneity, known as the \"delivery context.\" The concepts of adaptation and accessibility have been widely discussed and have resulted in many proposals, standards and techniques designed to solve the problem, making it necessary to refine the analysis of the issue to be considered in the process of adaptation. We present a tour of the various proposals and standards that have marked the area of heterogeneous systems works, and others who have worked since the real-time interaction through agents based platforms. All targeted to solve a common goal: the delivery context. [PUBLICATION ABSTRACT]

En el dise o y configuraci n de estas ortesis se encuentra un gran potencial en los materiales polim ricos para cumplir las funciones mec nicas que estas requieren, adem s de facilitar su elaboraci n por medio de la impresi n 3D, se experiment la variedad de materiales polim ricos de impresi n, sus densidades, flujos de inyecci n y rellenos para su conformaci n estructural. Se us un mecanismo de trinquete y u eta (ver Figura 1), para permitir la flexi n en la rodilla del paciente sin lastimar ni forzar la columna vertebral, complementado con una parte estructural que es el cuerpo de las ortesis (ver Figura 2) capaz de resistir pacientes de 100 kg. Al Instituto de Investigaci n e Innovaci n para el desarrollo tecnol gico (CIMADI) por la prestaci n de sus instalaciones y maquinas en el desarrollo experimental Y a todos los docentes del grupo de investigaci n DITMAV que de una u otra forma colaboraron con la realizaci n de este proyecto.

En la terapia física en la Clínica de Especialistas en Sogamoso se hace rehabilitación a pacientes con lesiones en las vértebras que le impiden levantarse o caminar, la cual se lleva a cabo con ortesis inadecuados según los requerimientos de la terapia, que generan incomodidades y esfuerzos tanto al paciente como al fisioterapeuta y tienen costos elevados. Se determinó dar solución a la problemática por medio del diseño y elaboración de ortesis que cumplan con los requerimientos de la fisioterapia, le den seguridad, estabilidad y comodidad al paciente. La elaboración de una estructura en acero recubierta y aislada en materiales poliméricos por medio de impresión 3D permitió generar una alternativa con características adecuadas para el objeto, debido a que poseen gran variedad de propiedades mecánicas. Se diseña y configura unas ortesis con unas características en su mecanismo que le permiten desempeñar su función de manera óptima con la fisioterapia. Asimismo, se logra la eliminación del esfuerzo físico realizado por el fisioterapeuta y el acompañante del paciente al levantarlo, y de igual manera, se logra que el paciente pueda ir de una posición sedente a una posición bípeda, mantenerse de pie y caminar, esto con comodidad y facilidad en su uso.

To accurately quantify the radioactivity concentration measured by PET, emission data need to be corrected for photon attenuation; however, the MRI signal cannot easily be converted into attenuation values, making attenuation correction (AC) in PET/MRI challenging. In order to further improve the current vendor-implemented MR-AC methods for absolute quantification, a number of prototype methods have been proposed in the literature. These can be categorized into three types: template/atlas-based, segmentation-based, and reconstruction-based. These proposed methods in general demonstrated improvements compared to vendor-implemented AC, and many studies report deviations in PET uptake after AC of only a few percent from a gold standard CT-AC. Using a unified quantitative evaluation with identical metrics, subject cohort, and common CT-based reference, the aims of this study were to evaluate a selection of novel methods proposed in the literature, and identify the ones suitable for clinical use. In total, 11 AC methods were evaluated: two vendor-implemented (MR-ACDIXON and MR-ACUTE), five based on template/atlas information (MR-ACSEGBONE (Koesters et al., 2016), MR-ACONTARIO (Anazodo et al., 2014), MR-ACBOSTON (Izquierdo-Garcia et al., 2014), MR-ACUCL (Burgos et al., 2014), and MR-ACMAXPROB (Merida et al., 2015)), one based on simultaneous reconstruction of attenuation and emission (MR-ACMLAA (Benoit et al., 2015)), and three based on image-segmentation (MR-ACMUNICH (Cabello et al., 2015), MR-ACCAR-RiDR (Juttukonda et al., 2015), and MR-ACRESOLUTE (Ladefoged et al., 2015)). We selected 359 subjects who were scanned using one of the following radiotracers: [18F]FDG (210), [11C]PiB (51), and [18F]florbetapir (98). The comparison to AC with a gold standard CT was performed both globally and regionally, with a special focus on robustness and outlier analysis. The average performance in PET tracer uptake was within ±5% of CT for all of the proposed methods, with the average±SD global percentage bias in PET FDG uptake for each method being: MR-ACDIXON (−11.3±3.5)%, MR-ACUTE (−5.7±2.0)%, MR-ACONTARIO (−4.3±3.6)%, MR-ACMUNICH (3.7±2.1)%, MR-ACMLAA (−1.9±2.6)%, MR-ACSEGBONE (−1.7±3.6)%, MR-ACUCL (0.8±1.2)%, MR-ACCAR-RiDR (−0.4±1.9)%, MR-ACMAXPROB (−0.4±1.6)%, MR-ACBOSTON (−0.3±1.8)%, and MR-ACRESOLUTE (0.3±1.7)%, ordered by average bias. The overall best performing methods (MR-ACBOSTON, MR-ACMAXPROB, MR-ACRESOLUTE and MR-ACUCL, ordered alphabetically) showed regional average errors within ±3% of PET with CT-AC in all regions of the brain with FDG, and the same four methods, as well as MR-ACCAR-RiDR, showed that for 95% of the patients, 95% of brain voxels had an uptake that deviated by less than 15% from the reference. Comparable performance was obtained with PiB and florbetapir. All of the proposed novel methods have an average global performance within likely acceptable limits (±5% of CT-based reference), and the main difference among the methods was found in the robustness, outlier analysis, and clinical feasibility. Overall, the best performing methods were MR-ACBOSTON, MR-ACMAXPROB, MR-ACRESOLUTE and MR-ACUCL, ordered alphabetically. These methods all minimized the number of outliers, standard deviation, and average global and local error. The methods MR-ACMUNICH and MR-ACCAR-RiDR were both within acceptable quantitative limits, so these methods should be considered if processing time is a factor. The method MR-ACSEGBONE also demonstrates promising results, and performs well within the likely acceptable quantitative limits. For clinical routine scans where processing time can be a key factor, this vendor-provided solution currently outperforms most methods. With the performance of the methods presented here, it may be concluded that the challenge of improving the accuracy of MR-AC in adult brains with normal anatomy has been solved to a quantitatively acceptable degree, which is smaller than the quantification reproducibility in PET imaging.